VYGR News and Press, Voyager Therapeutics Inc. From 01/04/24

LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) --  Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock (or pre-f...

2024-01-03 19:51:02 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ: ABVC), Neximmune Inc (NASDAQ: NEXI), Sidus Space Inc (NASDAQ: SIDU), Voyager Therapeutics Inc (NASDAQ: VYGR), and Cingulate...

2024-01-03 10:00:01 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...

LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced that Chief Executive Officer Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the 42 nd Annual J.P. Morgan...

2024-01-02 17:52:42 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Polished.com Inc (AMEX: POL), C4 Therapeutics Inc. (NASDAQ: CCCC),...

2024-01-02 12:56:48 ET More on Mid-day movers & stocks. ENDRA Life Sciences Inc. (NDRA) Q3 2023 Earnings Call Transcript PolyPid Ltd. (PYPD) Q3 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Endra Life Sciences Historical earnings da...

2024-01-02 10:09:39 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Longboard Pharmaceuticals Inc (NASDAQ: LBPH), Voyager Therapeutics Inc (NASDAQ: VYGR), Soligenix Inc (NASDAQ: ...

2024-01-02 08:24:37 ET DENVER, Colo., Jan. 2, 2024 ( www.247marketnews.com )- Voyager Therapeutics, Inc. (NASDAQ: VYGR) reported, this morning, that it formed a strategic collaboration and capsid license agreement with a Novartis AG (NYSE: NVS) to advance potential gene therapies for Hu...

2024-01-02 07:14:42 ET More on Novartis, Voyager Therapeutics, etc. Novartis: Post Investor Day, Higher Guidance Priced In Voyager Therapeutics' Strategic Partnerships And TRACER Technology - Speculative Buy Novartis AG (NVS) 10th Annual ESG Investor Event Conference...

- Collaboration with gene therapy leader Novartis aims to discover and develop new approaches for Huntington’s disease and spinal muscular atrophy - - Voyager to receive up-front consideration of $100 million and is eligible to receive milestone payments and tiered royalties - ...